Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women`s intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, and myQ products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle r...
Website: cutera.com



Growth: Bad revenue growth rate -28.3%, there is slowdown compared to average historical growth rates -7.9%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -75.6%. On average the margin is decreasing steadily. Gross margin is low, +5.6%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 40% of quarters (showing a gain of -$0.12 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -6 392.1% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 0.0% higher than minimum and 99.5% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued -2.9x by EV / Sales multiple

Key Financials (Download financials)

Ticker: CUTR
Share price, USD:  (0.0%)0.0969
year average price 0.0969  


year start price 0.0969 2025-07-26

max close price 0.0969 2025-07-26

min close price 0.0969 2025-07-26

current price 0.0969 2026-07-25
Common stocks: 19 858 000

Dividend Yield:  0.0%
EV / Sales: 2.4x
Margin (EBITDA LTM / Revenue): -75.6%
Fundamental value created in LTM:
Market Cap ($m): 2
Net Debt ($m): 375
EV (Enterprise Value): 377
Price to Book: 0.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-03-10businesswire.com

Cutera Announces Voluntarily Delisting from Nasdaq

2025-02-11globenewswire.com

Dermatology Devices Market Report 2025, with Key Player Profiles for Cutera, Lumenis, Alma Lasers, Solta Medical and Aesthetic Group

2024-11-09seekingalpha.com

Cutera, Inc. (CUTR) Q3 2024 Earnings Call Transcript

2024-11-07zacks.com

Cutera (CUTR) Reports Q3 Loss, Misses Revenue Estimates

2024-10-07businesswire.com

Cutera® to Announce Third Quarter Results on November 7, 2024

2024-08-10seekingalpha.com

Cutera, Inc (CUTR) Q2 2024 Earnings Call Transcript

2024-08-08zacks.com

Cutera (CUTR) Reports Q2 Loss, Misses Revenue Estimates

2024-06-10businesswire.com

Cutera® Appoints Jeryl L. Hilleman to Board of Directors

2024-06-06investorplace.com

If You Can Only Buy One Meme Stock Now, It Better Be One of These 3 Names

2024-06-06investorplace.com

Trade of the Day: Cutera (CUTR) Stock Presents a Short Squeeze Opportunity
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4 2019 q4
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31 2019-12-31
symbol CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-11-12 2024-08-09 2024-05-10 2024-03-05 2023-08-09 2023-05-10 2022-11-09
acceptedDate 2024-11-12 17:14:49 2024-08-09 16:48:27 2024-05-10 16:21:21 2024-05-10 16:15:53 2024-03-05 16:29:37 2023-08-09 16:39:48 2023-05-10 16:59:20 2023-04-07 17:08:06 2022-11-09 16:21:43 2022-03-01 16:39:22 2021-03-23 12:45:32 2020-03-16 17:06:15
calendarYear 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY FY
revenue 33M 34M 39M 212M 46M 61M 55M 252M 63M 231M 148M 182M
costOfRevenue 31M 28M 28M 171M 43M 33M 30M 113M 29M 98M 72M 84M
grossProfit 2M 6M 11M 41M 3M 28M 25M 140M 34M 133M 76M 98M
grossProfitRatio 0.056 0.182 0.284 0.074 0.458 0.453 0.545
researchAndDevelopmentExpenses 4M 4M 5M 21M 5M 6M 6M 25M 6M 22M 14M 15M
generalAndAdministrativeExpenses 15M 4M 13M 63M 17M 19M 13M 46M 11M 33M 32M 24M
sellingAndMarketingExpenses 19M 21M 24M 113M 26M 33M 30M 107M 26M 77M 53M 71M
sellingGeneralAndAdministrativeExpenses 34M 25M 35M 176M 40M 52M 42M 153M 37M 110M 84M 95M
otherExpenses 0 -387 000 -1M 0 -2M -453 000 -163 000 0 0 0 68 000 0
operatingExpenses 38M 28M 40M 198M 44M 58M 48M 178M 44M 131M 99M 110M
costAndExpenses 69M 56M 68M 369M 87M 91M 79M 291M 72M 229M 171M 194M
interestIncome 768 000 1M 1M 9M 2M 2M 2M 3M 2M 0 0 0
interestExpense 4M 4M 3M 14M 4M 3M 3M 6M 2M 3M 647 000 199 000
depreciationAndAmortization 2M 3M 3M 9M 5M 2M 3M 8M 539 000 5M 7M 4M
ebitda -34M -19M -26M -141M -36M -27M -20M -65M -9M 58 000 -17M -11M
ebitdaratio -1.04 -0.54 -0.664 -0.773 -0.433 -0.371 -0.142
operatingIncome -36M -22M -29M -156M -41M -30M -24M -38M -9M -1M -23M -12M
operatingIncomeRatio -1.114 -0.634 -0.751 -0.881 -0.482 -0.429 -0.15
totalOtherIncomeExpensesNet -2M -3M 6M -5M -3M -453 000 -1M -43M -2M 2M -579 000 -199 000
incomeBeforeTax -39M -25M -23M -161M -44M -31M -25M -81M -11M 3M -23M -12M
incomeBeforeTaxRatio -1.185 -0.719 -0.588 -0.949 -0.512 -0.45 -0.18
incomeTaxExpense 493 000 -19 000 -25 000 2M 167 000 326 000 272 000 2M 827 000 1M 470 000 85 000
netIncome -39M -25M -23M -163M -44M -32M -25M -82M -12M 2M -24M -12M
netIncomeRatio -1.201 -0.718 -0.587 -0.953 -0.517 -0.455 -0.193
eps -1.94 -1.23 -1.14 -8.19 -2.22 -1.59 -1.26 -4.39 -0.62 0.12 -1.43 -0.88
epsdiluted -1.94 -1.23 -1.14 -2.22 -1.59 -1.26 -0.62
weightedAverageShsOut 20M 20M 20M 20M 20M 20M 20M 19M 20M 18M 17M 14M
weightedAverageShsOutDil 20M 20M 20M 20M 20M 20M 20M 19M 20M 18M 17M 14M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2024-05-10 2023-04-07 2022-03-01 2021-03-23 2020-03-16
fiscalYear 2023 2022 2021 2020 2019
netInterestIncome -5M -4M -3M -647 000 -199 000
ebit -150M -75M 6M -23M -12M
nonOperatingIncomeExcludingInterest -7M 37M -4M -68 000 0
netIncomeFromContinuingOperations -163M -82M 2M -24M -12M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -163M -82M 2M -24M -12M
epsDiluted -8.19 -4.39 0.11 -1.43 -0.88

Balance Sheet Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4 2019 q4
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31 2019-12-31
symbol CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-11-12 2024-08-09 2024-05-10 2024-03-05 2023-08-09 2023-05-10 2022-11-09
acceptedDate 2024-11-12 17:14:49 2024-08-09 16:48:27 2024-05-10 16:21:21 2024-05-10 16:15:53 2024-03-05 16:29:37 2023-08-09 16:39:48 2023-05-10 16:59:20 2023-04-07 17:08:06 2022-11-09 16:21:43 2022-03-01 16:39:22 2021-03-23 12:45:32 2020-03-16 17:06:15
calendarYear 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY FY
cashAndCashEquivalents 58M 83M 105M 144M 180M 181M 167M 146M 46M 164M 47M 26M
shortTermInvestments 0 0 0 0 -16 000 42M 101M 171M 205M 0 0 8M
cashAndShortTermInvestments 58M 83M 105M 144M 180M 223M 268M 317M 251M 164M 47M 34M
netReceivables 33M 37M 46M 49M 55M 53M 61M 46M 36M 31M 22M 22M
inventory 57M 86M 80M 63M 73M 69M 72M 64M 56M 40M 29M 34M
otherCurrentAssets 13M 11M 3M 225 000 4M 25M 7000 22M 24M 15M 9M 6M
totalCurrentAssets 161M 211M 235M 269M 311M 370M 418M 451M 366M 250M 106M 95M
propertyPlantEquipmentNet 34M 40M 44M 47M 81M 77M 65M 53M 48M 18M 19M 11M
goodwill 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
intangibleAssets 0 0 0 0 0 1M 0 0 0 0 0 0
goodwillAndIntangibleAssets 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
longTermInvestments 0 1M 0 0 -1 0 0 0 0 700 000 0 0
taxAssets 590 000 508 000 534 000 579 000 528 000 547 000 577 000 590 000 626 000 778 000 643 000 423 000
otherNonCurrentAssets 38M 23M 31M 28M 13M 15M 14M 15M 12M 10M 5M 6M
totalNonCurrentAssets 74M 65M 77M 77M 95M 94M 81M 70M 62M 31M 26M 19M
otherAssets 0 0 0 0 1 0 0 0 0 0 0 0
totalAssets 234M 276M 312M 346M 407M 464M 500M 521M 428M 280M 133M 114M
accountPayables 8M 18M 13M 20M 31M 34M 35M 34M 34M 8M 7M 13M
shortTermDebt 3M 4M 4M 0 3M 3M 3M 0 3M 554 000 4M 541 000
taxPayables 0 3M 7M 6M 5M 10M 10M 9M 6M 9M 5M 4M
deferredRevenue 8M 9M 9M 10M 11M 12M 12M 12M 11M 9M 9M 11M
otherCurrentLiabilities 36M 27M 46M 40M 46M 54M 59M 38M 51M 32M 20M 18M
totalCurrentLiabilities 56M 60M 73M 88M 92M 103M 109M 106M 98M 74M 51M 56M
longTermDebt 429M 430M 419M 419M 418M 428M 428M 416M 312M 134M 4M 0
deferredRevenueNonCurrent 0 2M 1M 1M 2M 2M 2M 2M 2M 1M 2M 3M
deferredTaxLiabilitiesNonCurrent 0 0 11M 0 11M 0 0 0 0 0 0 93 000
otherNonCurrentLiabilities 3M 519 000 234 000 234 000 36 000 575 000 711 000 862 000 267M 763 000 242 000 671 000
totalNonCurrentLiabilities 432M 432M 432M 430M 430M 430M 430M 430M 314M 150M 25M 12M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 12M 14M 11M 13M 11M 13M 13M 15M 14M 16M 18M 8M
totalLiabilities 487M 492M 505M 518M 523M 533M 539M 536M 413M 224M 76M 68M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 20 000 20 000 20 000 20 000 20 000 20 000 20 000 20 000 20 000 18 000 18 000 14 000
retainedEarnings -390M -351M -326M -303M -246M -197M -166M -141M -133M -58M -60M -36M
accumulatedOtherComprehensiveIncomeLoss 0 0 0 0 0 4000 -8000 -94 000 -336 000 0 0 -60 000
othertotalStockholdersEquity 137M 135M 134M 130M 128M 127M 149M
totalStockholdersEquity -253M -216M -193M -172M -116M -69M -39M -15M 15M 57M 57M 46M
totalEquity -253M -216M -193M -172M -116M -69M -39M -15M 15M 57M 57M 46M
totalLiabilitiesAndStockholdersEquity 234M 276M 312M 407M 464M 500M 428M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 234M 276M 312M 346M 407M 464M 500M 521M 428M 280M 133M 114M
totalInvestments 0 1M 0 0 -16 000 42M 101M 171M 205M 700 000 0 8M
totalDebt 432M 434M 434M 432M 432M 430M 430M 431M 315M 150M 25M 8M
netDebt 375M 351M 329M 288M 252M 250M 264M 285M 269M -14M -22M -18M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2024-05-10 2023-04-07 2022-03-01 2021-03-23 2020-03-16
fiscalYear 2023 2022 2021 2020 2019
accountsReceivables 43M 46M 31M 22M 22M
otherReceivables 6M 0 0 0 0
prepaids 13M 17M 0 0 0
totalPayables 20M 34M 8M 7M 13M
otherPayables 0 0 0 0 0
accruedExpenses 14M 19M 22M 12M 14M
capitalLeaseObligationsCurrent 3M 3M 2M 2M 3M
capitalLeaseObligationsNonCurrent 10M 11M 13M 16M 5M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 131M 125M 115M 117M 82M
otherTotalStockholdersEquity 0 0 0 -0 0

Cash Flow Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4 2019 q4
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31 2019-12-31
symbol CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR CUTR
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-11-12 2024-08-09 2024-05-10 2024-03-05 2023-08-09 2023-05-10 2022-11-09
acceptedDate 2024-11-12 17:14:49 2024-08-09 16:48:27 2024-05-10 16:21:21 2024-05-10 16:15:53 2024-03-05 16:29:37 2023-08-09 16:39:48 2023-05-10 16:59:20 2023-04-07 17:08:06 2022-11-09 16:21:43 2022-03-01 16:39:22 2021-03-23 12:45:32 2020-03-16 17:06:15
calendarYear 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY FY
netIncome -39M -25M -23M -163M -44M -32M -25M -82M -12M 2M -24M -12M
depreciationAndAmortization 2M 3M 3M 9M 5M 2M 1M 3M 674 000 1M 1M 2M
deferredIncomeTax -82 000 26 000 45 000 11 000 19 000 30 000 13 000 188 000 72 000 -135 000 -220 000 34 000
stockBasedCompensation 2M 2M 2M 8M 2M 2M 3M 14M 4M 13M 10M 10M
changeInWorkingCapital 14M -4M -23M -11M -4M -7M -19M -42M -13M -11M -11M -5M
accountsReceivables -3M -287 000 4M -5M 276 000 -3M -7M -16M -4M -10M -3M -3M
inventory 12M 3M -11M 16M 2M 3M -8M -35M -11M -11M 5M -6M
accountsPayables -10M 4M -7M -15M -3M -336 000 -1M 21M 6M 1M -6M 1M
otherWorkingCapital 15M -10M -9M -7M -4M -7M -2M -12M -4M 8M -8M 2M
otherNonCashItems -3M 4M 26M 20M 5M 4M 2M 40M 547 000 -4M 7M 4M
netCashProvidedByOperatingActivities -25M -20M -38M -138M -37M -31M -37M -67M -20M 1M -17M -2M
investmentsInPropertyPlantAndEquipment -173 000 -882 000 -335 000 -33M -6M -15M -11M -23M -6M -1M -1M -991 000
acquisitionsNet 0 6000 57 000 0 0 0 11M 23M 0 71 000 30 000 45 000
purchasesOfInvestments 0 0 0 -23M 0 0 -23M -329M -49M 0 -26M -13M
salesMaturitiesOfInvestments 0 63 000 0 194M 41M 60M 95M 158M 47M 0 34M 15M
otherInvestingActivites 0 -882 000 -278 000 39M 0 -11M 0
netCashUsedForInvestingActivites -173 000 -876 000 -278 000 36M 45M 60M -8M
debtRepayment -393 000 7000 -196 000 -149 000 -113 000 -124 000 -108 000
commonStockIssued 0 0 0 465 000 749 000 109 000 248 000
commonStockRepurchased 0 -20 000 -64 000 -3M -87 000 -789 000 0 -57M 0 -16M 0 -831 000
dividendsPaid 0 0 0 0 -40 000 0 0
otherFinancingActivites -26 000 -20 000 -64 000 -87 000 40 000 -2M -2M
netCashUsedProvidedByFinancingActivities -419 000 -13 000 -260 000 229 000 -153 000 -2M -1M
effectOfForexChangesOnCash 0 0 0 0 0 0 0 0 0 0 0 0
netChangeInCash -24M -22M -38M -3M -1M 14M 21M -18M -29M 118M 21M 264 000
cashAtEndOfPeriod 59M 83M 105M 144M 180M 181M 168M 147M 47M 165M 47M 26M
cashAtBeginningOfPeriod 83M 105M 144M 147M 181M 168M 147M 165M 76M 47M 26M 26M
operatingCashFlow -25M -20M -38M -138M -37M -31M -37M -67M -20M 1M -17M -2M
capitalExpenditure -173 000 -882 000 -335 000 -33M -6M -15M -11M -23M -6M -1M -1M -991 000
freeCashFlow -25M -21M -38M -171M -42M -46M -48M -90M -26M 220 000 -18M -3M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2024-05-10 2023-04-07 2022-03-01 2021-03-23 2020-03-16
fiscalYear 2023 2022 2021 2020 2019
otherInvestingActivities 0 -23M 70 999 8M 2M
netCashProvidedByInvestingActivities 137M -194M -944 000 6M 1M
netDebtIssuance -594 000 314M 138M 7M -649 000
longTermNetDebtIssuance -594 000 314M 138M 7M -649 000
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 0 -54M -13M 29M 0
netCommonStockIssuance 0 -54M -13M 29M 0
commonStockIssuance 1M 3M 3M 29M 3M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -2M -17M -7M -4M 2M
netCashProvidedByFinancingActivities -3M 243M 118M 31M 1M
incomeTaxesPaid 1M 2M 891 000 0 59 000
interestPaid 12M 5M 2M 0 81 000

Earning call transcript

2024 q3
2024-11-09 ET (fiscal 2024 q3)
2024 q1
2024-05-09 ET (fiscal 2024 q1)
2023 q4
2024-03-21 ET (fiscal 2023 q4)
2023 q3
2023-11-08 ET (fiscal 2023 q3)
2023 q2
2023-08-08 ET (fiscal 2023 q2)
2023 q1
2023-05-09 ET (fiscal 2023 q1)
2022 q4
2023-02-28 ET (fiscal 2022 q4)
2022 q3
2022-11-05 ET (fiscal 2022 q3)
2022 q2
2022-08-07 ET (fiscal 2022 q2)
2022 q1
2022-05-10 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2025-03-10 ET
Cutera Announces Voluntarily Delisting from Nasdaq
2025-03-05 ET
Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success
2024-11-12 ET
Cutera® Announces Partnership with the Adaptive Training Foundation
2024-11-07 ET
Cutera® Announces Third Quarter 2024 Financial Results
2024-10-07 22:48 ET
Cutera® to Announce Third Quarter Results on November 7, 2024
2024-08-08 20:01 ET
Cutera® Announces Second Quarter 2024 Financial Results
2024-07-31 12:00 ET
Cutera® Announces Exclusive Distribution Agreement With L’Oréal® for SkinCeuticals® Products in Japan
2024-07-26 15:53 ET
Cutera® to Announce Second Quarter Results on August 8, 2024
2024-07-19 12:33 ET
The Kaga Institute Introduces Advanced Secret Duo Skin Rejuvenation Service
2024-06-13 12:30 ET
Cutera® Announces New Survey Data During Acne Awareness Month
2024-06-10 20:30 ET
Cutera® Appoints Jeryl L. Hilleman to Board of Directors
2024-06-07 12:30 ET
Cutera® Announces AviClear® Investor Webinar
2024-05-30 21:57 ET
Cutera, Inc. Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
2024-05-21 14:00 ET
Cutera, Inc. Investor Alert (NASDAQ: CUTR): Schubert Jonckheer & Kolbe LLP Investigating Potential Claims Against the Company's Officers and Directors
2024-05-09 20:01 ET
Cutera Announces First Quarter 2024 Financial Results
2024-04-26 12:00 ET
Cutera to Announce First Quarter Results on May 9, 2024
2024-04-11 12:00 ET
Cutera® Announces the North America Launch of xeo®+
2024-03-21 20:01 ET
Cutera Announces Fourth Quarter and Full-Year 2023 Financial Results Along with 2024 Outlook
2024-03-01 13:30 ET
Cutera to Announce Fourth Quarter and Full-Year 2023 Results on March 21, 2024
2024-02-08 13:00 ET
Cutera Announces the International Limited Commercial Release of AviClear® at IMCAS World Congress 2024
2024-01-09 13:00 ET
Cutera, Inc. Announces Preliminary Unaudited Financial Results for Full-Year 2023
2023-11-20 13:00 ET
Justera Revenue Boosts with Launching of Cutera XEO Laser Treatment and Plan to Expand
2023-11-16 23:05 ET
Cutera, Inc. Reports Inducement Grants as permitted by the Nasdaq Listing Rules
2023-11-16 23:00 ET
Cutera, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-Q
2023-11-13 13:30 ET
Cutera Appoints Stephana Patton as Chief Legal Officer
2023-11-10 22:07 ET
Cutera, Inc. to Participate in Upcoming Investor Conferences
2023-11-08 21:01 ET
Cutera Provides Third Quarter 2023 Business Update
2023-11-08 13:00 ET
Justera Launches Premium Laser Treatment with CUTERA XEO
2023-10-26 00:06 ET
Cutera, Inc. to Announce Third Quarter Results on November 8, 2023
2023-10-06 21:00 ET
Cutera Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
2023-10-02 12:30 ET
Cutera, Inc. Appoints Brent Hauser as President, International
2023-09-07 12:00 ET
Cutera Announces the Launch of New Skin Resurfacing and Revitalization Platform Secret DUO®
2023-09-01 22:30 ET
Cutera Reports Inducement Grants as permitted by the Nasdaq Listing Rules
2023-08-24 13:00 ET
Cutera, Inc. Appoints Jeff Jones as Chief Operating Officer
2023-08-08 20:01 ET
Cutera Announces Second Quarter 2023 Financial Results along with 2023 Outlook
2023-07-27 13:00 ET
Cutera, Inc. Appoints Taylor Harris as Chief Executive Officer
2023-07-22 00:00 ET
Cutera, Inc. to Announce Second Quarter Results on August 8, 2023
2023-07-10 13:10 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-07-10 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-07-04 13:20 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-07-04 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-29 13:20 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-06-29 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-06-26 13:20 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-26 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-20 13:30 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-06-20 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-06-19 12:30 ET
Cutera, Inc. to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on Tuesday, June 20th
2023-06-15 13:03 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-15 12:30 ET
FDA Clears AviClear® as a Long-Term Treatment for Mild to Severe Acne
2023-06-15 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-12 13:30 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-06-12 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-06-06 13:30 ET
Cutera Investors: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-06 ET
Cutera Investors: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-02 17:55 ET
Cutera Investors: July 24, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-02 ET
Cutera Investors: July 24, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-01 12:30 ET
Cutera® Celebrates One Year of Revolutionizing the Acne Market with AviClear® During Acne Awareness Month
2023-05-15 20:15 ET
Cutera Cancels Special Meeting
2023-05-12 13:00 ET
Cutera Comments on Termination of Voce Capital’s Special Meeting Proxy Solicitation
2023-05-11 20:16 ET
Voce Capital Provides Update on Cutera Special Meeting
2023-05-09 21:09 ET
Cutera Announces Agreements with Pura Vida and RTW
2023-05-09 20:01 ET
Cutera Announces First Quarter 2023 Financial Results
2023-04-25 00:30 ET
Cutera, Inc. to Announce First Quarter Results on May 9, 2023
2023-04-18 20:15 ET
Cutera Directors J. Daniel Plants and David Mowry Respond to Special Committee’s Attempt to Rewrite History
2023-04-17 12:00 ET
Cutera, Inc.’s Special Committee Updates Stockholders on Its Recent Steps to Protect Stockholder Interests
2023-04-14 12:00 ET
Cutera® Celebrates 25 Years of Excellence in Innovation
2023-04-13 20:01 ET
Cutera, Inc. to Hold Special Meeting of Stockholders
2023-04-12 21:55 ET
RTW Investments, LP Issues Statement Regarding Cutera's Special Meeting of Stockholders
2023-04-12 20:35 ET
Cutera Directors J. Daniel Plants and David Mowry Take Legal Action to Ensure Shareholders Have a Say in Composition of Cutera’s Board and Selection of its Next CEO
2023-04-12 10:00 ET
Cutera, Inc. Announces Executive Leadership and Governance Changes
2023-04-11 20:49 ET
David Mowry and J. Daniel Plants Share Letter of Support from Cutera Senior Leaders Sent to Company’s Board
2023-04-11 19:41 ET
Pura Vida Investments Calls for Cutera Board to Immediately Extend Director Nomination Deadline
2023-04-10 22:00 ET
Cutera Regains Compliance with Nasdaq Listing Rules
2023-04-10 11:35 ET
J. Daniel Plants and David Mowry Call for Special Stockholder Meeting to Reconstitute Cutera’s Board
2023-04-07 19:30 ET
Cutera, Inc. Acknowledges Receipt of Special Meeting Demand from Daniel Plants
2023-03-24 21:15 ET
Cutera Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-K
2023-03-14 12:00 ET
Cutera® Unveils the Reimagined truBody® Brand
2023-02-28 21:01 ET
Cutera Announces Fourth Quarter and Full-Year 2022 Financial Results along with 2023 Outlook
2023-02-15 02:15 ET
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2022 Results on February 28, 2023
2023-01-09 13:30 ET
Cutera, Inc. Announces Preliminary Unaudited Financial Results for Full-Year 2022
2022-12-08 12:00 ET
Cutera, Inc. Announces Pricing of Offering of $100 Million of Convertible Senior Notes
2022-12-08 ET
Cutera, Inc. Announces Pricing of Offering of $100 Million of Convertible Senior Notes
2022-12-07 21:01 ET
Cutera, Inc. Announces Proposed Private Offering of $100 Million of Convertible Senior Notes
2022-12-07 ET
Cutera, Inc. Announces Proposed Private Offering of $100 Million of Convertible Senior Notes
2022-12-01 21:30 ET
Cutera, Inc. Provides Response to FDA Inquiry
2022-11-21 22:00 ET
Cutera, Inc. to Participate in a Fireside Chat at the 34th Annual Piper Sandler Healthcare Conference
2022-11-10 22:10 ET
Cutera, Inc. to Participate in a Fireside Chat at the Stephens Annual Investment Conference
2022-11-10 22:10 ET
Cutera, Inc. to Participate in a Fireside Chat at the Stifel Healthcare 2022 Conference
2022-11-07 13:01 ET
AviClear™ Now Broadly Available to US Physicians and Practitioners Upon National Launch
2022-11-03 20:01 ET
Cutera Announces Third Quarter 2022 Financial Results
2022-10-25 12:01 ET
Cutera’s AviClearTM 12-Month Clinical Data Presented at the 42nd Annual Fall Clinical Dermatology Conference
2022-10-20 21:53 ET
Cutera, Inc. to Announce Third Quarter Results on November 3, 2022
2022-09-08 12:00 ET
Cutera Announces Over 1,000 AviClear™ Acne Treatments Performed
2022-08-04 20:01 ET
Cutera Announces Second Quarter 2022 Financial Results
2022-07-28 22:39 ET
Cutera, Inc. to Announce Second Quarter Results on August 4, 2022
2022-07-13 13:00 ET
Health Canada Clears Cutera’s AviClear™
2022-06-13 12:00 ET
New Research Reveals Roughly 4 in 5 Moderate to Severe Acne Sufferers Have Missed Moments in Their Life Due to Acne
2022-05-25 07:15 ET
Cutera, Inc. Announces Pricing of Offering of $200 Million and Concurrent Private Placement of $10 Million of Convertible Senior Notes
2022-05-25 ET
Cutera, Inc. Announces Pricing of Offering of $200 Million and Concurrent Private Placement of $10 Million of Convertible Senior Notes
2022-05-24 11:47 ET
Cutera, Inc. Announces Proposed Private Offering of $200 Million of Convertible Senior Notes
2022-05-24 ET
Cutera, Inc. Announces Proposed Private Offering of $200 Million of Convertible Senior Notes
2022-05-10 20:01 ET
Cutera Announces Record First Quarter 2022 Revenue Results
2022-05-02 12:00 ET
Cutera’s AviClear™ Clinical Data Presented at the Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS)
2022-04-28 02:12 ET
Cutera, Inc. to Announce First Quarter Results on May 10, 2022
2022-04-20 12:00 ET
Cutera Partners with Synchrony to Provide Financing Options to Dermatology Patients for Innovative New Acne Treatment
2022-04-05 12:00 ET
Cutera Announces First Patient Treated with FDA Cleared AviClear™ Acne Device
2022-03-25 12:00 ET
FDA Clears Cutera’s AviClear™ Acne Device
2022-03-24 18:05 ET
Cutera, Inc. to Participate in the Aesthetic Device Industry Panel at the Maxim Virtual Growth Conference
2022-02-22 21:01 ET
Cutera, Inc. Announces Fourth Quarter and Full-Year 2021 Financial Results Along With 2022 Outlook
2022-01-31 23:52 ET
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2021 Results on February 22, 2022
2021-12-13 13:59 ET
Cutera Appoints Janet Widmann and Juliane Park to Its Board of Directors
2021-12-01 16:34 ET
Cutera Launches Next Gen Rapid Muscle Sculpting with truSculpt® flex+
2021-11-23 20:20 ET
Cutera, Inc. to Participate in the Piper Sandler Virtual Healthcare Conference
2021-11-11 00:18 ET
Cutera, Inc. to Participate in a Virtual Fireside Chat at the Stifel Healthcare Conference
2021-11-03 20:01 ET
Cutera, Inc. Announces Third Quarter 2021 Financial Results; Raises Full-year Revenue Guidance
2021-10-12 22:00 ET
Cutera, Inc. to Announce Third Quarter Results on November 3, 2021
2021-09-16 23:00 ET
Cutera, Inc. to Participate in a Virtual Fireside Chat at the Cantor Fitzgerald Global Healthcare Conference
2021-08-04 20:01 ET
Cutera, Inc. Announces Second Quarter 2021 Financial Results with Record Revenue and Issues 2021 Guidance
2021-07-15 20:01 ET
CORRECTING and REPLACING Cutera, Inc. to Announce Second Quarter Results on August 4, 2021
2021-06-16 20:13 ET
Cutera Announces Renewal of Distribution Agreement with ZO Skin Health
2021-05-17 20:01 ET
Cutera Appoints Sheila Hopkins to its Board of Directors
2021-05-10 21:05 ET
Cutera to Present at the UBS Global Healthcare Conference
2021-05-05 20:04 ET
Cutera, Inc. Announces Departure of Jason Richey
2021-05-05 20:01 ET
Cutera, Inc. Announces First Quarter 2021 Financial Results
2021-04-22 00:00 ET
Cutera, Inc. to Announce First Quarter Results on May 5, 2021
2021-03-17 12:01 ET
The Spa at Nita Lake Lodge Unveils Award Winning Technologies by Cutera(R)
2021-03-05 12:01 ET
Cutera, Inc. Announces Pricing of Offering of $125 Million of Convertible Senior Notes
2021-03-03 22:05 ET
Cutera, Inc. Announces Proposed Private Offering of $125 Million of Convertible Senior Notes
2021-02-17 21:01 ET
Cutera, Inc. Announces Fourth Quarter and Full-Year 2020 Financial Results
2021-02-02 12:00 ET
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2020 Results on February 17, 2021
2020-11-24 17:59 ET
Cutera to Participate in the Piper Sandler Virtual Healthcare Conference
2020-11-12 21:17 ET
Cutera to Participate in Two Virtual Fireside Chats at Investor Conferences in November
2020-11-04 21:01 ET
Cutera, Inc. Announces Third Quarter 2020 Financial Results
2020-10-19 16:51 ET
Power Couple Becomes First to Flex Muscles in Calgary
2020-10-15 13:16 ET
Cutera, Inc. to Announce Third Quarter Results on November 4, 2020
2020-09-10 20:01 ET
Cutera to Participate in a Virtual Fireside Chat at the Cantor Global Healthcare Conference
2020-09-01 15:08 ET
Industry Leading truSculpt® flex Launches Its Muscle in Canada
2020-08-24 15:11 ET
Cutera Reverses Aging, Unveils Powerful Technology
2020-08-07 20:01 ET
Cutera to Present at the Canaccord Genuity Growth Conference
2020-08-06 20:05 ET
Cutera Appoints Rohan Seth as Chief Financial Officer
2020-08-06 20:01 ET
Cutera, Inc. Announces Second Quarter 2020 Financial Results
2020-07-29 11:00 ET
Cutera, Inc. to Announce Second Quarter Results on August 6, 2020
2020-07-14 20:01 ET
Cutera to Participate in Maxim Group’s “Re-Engaging Medical Practices in an Era of COVID-19” Webinar
2020-05-18 20:01 ET
Cutera to Present at the UBS Global Healthcare Conference
2020-05-07 20:01 ET
Cutera, Inc. Announces First Quarter 2020 Financial Results
2020-05-04 11:05 ET
truSculpt® flex From Cutera, Inc. Wins 2020 Good Housekeeping Award
2020-04-30 20:01 ET
Cutera, Inc. to Announce First Quarter Results on May 7, 2020
2020-04-21 20:24 ET
Cutera, Inc. Announces Closing of Public Stock Offering and Full Exercise of Underwriter’s Option to Purchase Additional Stock
2020-04-17 02:12 ET
Cutera, Inc. Announces Pricing of Public Offering of Common Stock
2020-04-16 20:04 ET
Cutera, Inc. Announces Proposed Public Offering of Common Stock
2020-02-26 21:10 ET
Cutera, Inc. Announces Fourth Quarter and Full-Year 2019 Financial Results
2020-02-13 21:41 ET
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2019 Results on February 26, 2020
2020-01-13 00:00 ET
Cutera Announces Preliminary Financial Results for Fourth Quarter and Full-Year 2019
2019-12-03 01:00 ET
Cutera to Present at the Piper Jaffray 31st Annual Healthcare Conference
2019-11-18 13:00 ET
Cutera Appoints Fuad Ahmad as Interim CFO
2019-11-07 21:05 ET
Cutera Reports Third Quarter 2019 Financial Results
2019-10-22 20:05 ET
Cutera, Inc. to Announce Third Quarter 2019 Results
2019-09-12 20:00 ET
Cutera Receives Additional Approval from Health Canada for its truSculpt® iD Body Sculpting Technology
2019-09-09 12:30 ET
Cutera to Present at Upcoming Investor Conferences
2019-04-18 20:05 ET
Cutera, Inc. to Announce First Quarter 2019 Results
2019-04-18 00:00 ET
Cutera Announces Regulatory Approval of Secret™ RF Microneedling System in Canada

SEC forms

Show financial reports only

SEC form 10
2024-11-12 17:14 ET
Cutera reported for 2024 q3
SEC form 10
2024-11-12 00:00 ET
Cutera reported for 2024 q3
SEC form 8
2024-11-07 16:08 ET
Cutera reported for 2024 q3
SEC form 8
2024-11-07 16:08 ET
Cutera published news for 2024 q3
SEC form 10
2024-08-09 16:48 ET
Cutera reported for 2024 q2
SEC form 10
2024-08-09 00:00 ET
Cutera reported for 2024 q2
SEC form 8
2024-08-08 16:07 ET
Cutera published news for 2024 q2
SEC form 8
2024-08-08 16:07 ET
Cutera reported for 2024 q2
SEC form 10
2024-05-10 00:00 ET
Cutera published news for 2024 q1
SEC form 10
2024-05-10 00:00 ET
Cutera published news for 2023 q4
SEC form 8
2024-05-09 00:00 ET
Cutera published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Cutera reported for 2024 q1
SEC form 8
2024-03-21 16:02 ET
Cutera published news for 2023 q4
SEC form 8
2024-03-21 16:02 ET
Cutera reported for 2023 q4
SEC form 8
2024-03-05 16:34 ET
Cutera published news for 2023 q4
SEC form 8
2024-03-05 16:34 ET
Cutera published news for 2023 q4
SEC form 8
2024-03-05 16:31 ET
Cutera published news for 2023 q4
SEC form 8
2024-03-05 16:31 ET
Cutera published news for 2023 q4
SEC form 10
2024-03-05 16:29 ET
Cutera reported for 2023 q3
SEC form 8
2024-03-05 16:18 ET
Cutera published news for 2023 q4
SEC form 8
2024-03-05 16:18 ET
Cutera published news for 2023 q4
SEC form 10
2024-03-05 00:00 ET
Cutera reported for 2023 q3
SEC form 8
2024-01-09 00:00 ET
Cutera published news for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Cutera published news for 2023 q4
SEC form 8
2023-11-08 16:06 ET
Cutera published news for 2023 q3
SEC form 10
2023-08-09 16:39 ET
Cutera published news for 2023 q2
SEC form 10
2023-08-09 00:00 ET
Cutera published news for 2023 q2
SEC form 6
2023-08-08 16:07 ET
Cutera reported for 2023 q2
SEC form 8
2023-08-08 00:00 ET
Cutera published news for 2023 q2
SEC form 6
2023-07-31 16:22 ET
Cutera published news for 2023 q2
SEC form 6
2023-07-17 16:08 ET
Cutera published news for 2023 q2
SEC form 6
2023-06-09 16:32 ET
Cutera published news for 2023 q1
SEC form 10
2023-05-10 00:00 ET
Cutera published news for 2023 q1
SEC form 6
2023-04-20 08:26 ET
Cutera published news for 2023 q1
SEC form 6
2023-04-17 08:37 ET
Cutera published news for 2023 q1
SEC form 6
2023-04-13 17:02 ET
Cutera published news for 2023 q1
SEC form 6
2023-04-12 17:07 ET
Cutera published news for 2023 q1
SEC form 10
2023-04-07 17:08 ET
Cutera published news for 2022 q4
SEC form 6
2023-04-07 15:55 ET
Cutera published news for 2023 q1
SEC form 10
2023-04-07 00:00 ET
Cutera reported for 2022 q4
SEC form 6
2023-03-24 17:24 ET
Cutera published news for 2022 q4
SEC form 6
2023-03-16 16:05 ET
Cutera published news for 2022 q4
SEC form 6
2023-02-28 17:15 ET
Cutera published news for 2022 q4
SEC form 6
2023-02-28 16:07 ET
Cutera published news for 2022 q4
SEC form 8
2023-02-28 00:00 ET
Cutera reported for 2022 q4
SEC form 6
2023-01-09 08:34 ET
Cutera published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Cutera published news for 2022 q4
SEC form 6
2022-12-12 16:06 ET
Cutera published news for 2022 q3
SEC form 6
2022-12-07 16:03 ET
Cutera published news for 2022 q3
SEC form 8
2022-12-07 00:00 ET
Cutera published news for 2022 q3
SEC form 6
2022-12-01 16:40 ET
Cutera published news for 2022 q3
SEC form 10
2022-11-09 16:21 ET
Cutera published news for 2022 q3
SEC form 10
2022-11-09 00:00 ET
Cutera reported for 2022 q3
SEC form 6
2022-11-03 16:14 ET
Cutera published news for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Cutera reported for 2022 q3
SEC form 6
2022-11-01 16:08 ET
Cutera published news for 2022 q3
SEC form 6
2022-09-23 17:43 ET
Cutera published news for 2022 q2
SEC form 10
2022-08-08 17:01 ET
Cutera published news for 2022 q2
SEC form 10
2022-08-08 00:00 ET
Cutera reported for 2022 q2
SEC form 6
2022-08-05 11:46 ET
Cutera published news for 2022 q2
SEC form 8
2022-08-05 00:00 ET
Cutera reported for 2022 q2
SEC form 6
2022-06-17 17:08 ET
Cutera published news for 2022 q1
SEC form 6
2022-05-31 16:43 ET
Cutera published news for 2022 q1
SEC form 6
2022-05-24 08:37 ET
Cutera published news for 2022 q1
SEC form 8
2022-05-24 00:00 ET
Cutera published news for 2022 q1
SEC form 10
2022-05-10 16:25 ET
Cutera published news for 2022 q1
SEC form 6
2022-05-10 16:22 ET
Cutera published news for 2022 q1
SEC form 8
2022-05-10 00:00 ET
Cutera reported for 2022 q1
SEC form 10
2022-05-10 00:00 ET
Cutera reported for 2022 q1
SEC form 6
2022-05-02 12:37 ET
Cutera published news for 2022 q1
SEC form 10
2022-03-01 16:39 ET
Cutera published news for 2021 q4
SEC form 10
2022-03-01 00:00 ET
Cutera published news for 2021 q4
SEC form 6
2022-02-22 16:14 ET
Cutera published news for 2021 q4
SEC form 8
2022-02-22 00:00 ET
Cutera published news for 2021 q4
SEC form 6
2021-12-13 17:06 ET
Cutera published news for 2021 q3
SEC form 10
2021-11-04 16:52 ET
Cutera published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Cutera published news for 2021 q3
SEC form 6
2021-11-03 16:10 ET
Cutera published news for 2021 q3
SEC form 8
2021-11-03 00:00 ET
Cutera published news for 2021 q3
SEC form 10
2021-08-06 17:01 ET
Cutera published news for 2021 q2
SEC form 10
2021-08-06 00:00 ET
Cutera published news for 2021 q2
SEC form 6
2021-08-04 16:31 ET
Cutera published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
Cutera published news for 2021 q2
SEC form 6
2021-06-17 18:06 ET
Cutera published news for 2021 q1
SEC form 6
2021-05-25 17:14 ET
Cutera published news for 2021 q1
SEC form 6
2021-05-24 20:59 ET
Cutera published news for 2021 q1
SEC form 6
2021-05-17 16:03 ET
Cutera published news for 2021 q1
SEC form 6
2021-05-12 13:55 ET
Cutera published news for 2021 q1
SEC form 10
2021-05-10 06:04 ET
Cutera published news for 2021 q1
SEC form 10
2021-05-10 00:00 ET
Cutera published news for 2021 q1
SEC form 6
2021-05-05 16:21 ET
Cutera published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
Cutera published news for 2021 q1
SEC form 6
2021-04-30 09:05 ET
Cutera published news for 2021 q1
SEC form 10
2021-03-23 12:45 ET
Cutera published news for 2020 q4
SEC form 6
2021-03-17 16:12 ET
Cutera published news for 2020 q4
SEC form 6
2021-03-09 16:32 ET
Cutera published news for 2020 q4
SEC form 6
2021-03-03 17:23 ET
Cutera published news for 2020 q4
SEC form 6
2021-02-17 17:11 ET
Cutera published news for 2020 q4
SEC form 10
2020-11-09 15:56 ET
Cutera published news for 2020 q3
SEC form 6
2020-11-04 17:15 ET
Cutera published news for 2020 q3